CoChat

Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia

Open access
Montefiori, Lindsey E., Bendig, Sonja, Gu, Zhaohui, Chen, Xiaolong, Pölönen, Petri, Ma, Xiaotu, Murison, Alex, Zeng, Andy, Garcia-Prat, Laura, Dickerson, Kirsten, Iacobucci, Ilaria, Abdelhamed, Sherif, Hiltenbrand, Ryan, Mead, Paul E., Mehr, Cyrus M., Xu, Beisi, Cheng, Zhongshan, Chang, Ti-Cheng, Westover, Tamara, Ma, Jing, Stengel, Anna, Kimura, Shunsuke, Qu, Chunxu, Valentine, Marcus B., Rashkovan, Marissa, Luger, Selina, Litzow, Mark R., Rowe, Jacob M., den Boer, Monique L., Wang, Victoria, Yin, Jun, Kornblau, Steven M., Hunger, Stephen P., Loh, Mignon L., Pui, Ching-Hon, Yang, Wenjian, Crews, Kristine R., Roberts, Kathryn G., Yang, Jun J., Relling, Mary V., Evans, William E., Stock, Wendy, Paietta, Elisabeth M., Ferrando, Adolfo A., Zhang, Jinghui, Kern, Wolfgang, Haferlach, Torsten, Wu, Gang, Dick, John E., Klco, Jeffery M., Haferlach, Claudia, Mullighan, Charles G. · 2021 · Cancer Discovery
Cited by 180

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Lineage-ambiguous leukemias are high-risk malignancies of poorly understood genetic basis. Here, we describe a distinct subgroup of acute leukemia with expression of myeloid, T lymphoid, and stem cell markers driven by aberrant allele-specific deregulation of BCL11B, a master transcription factor responsible for thymic T-lineage commitment and specification. Mechanistically, this deregulation was driven by chromosomal rearrangements that juxtapose BCL11B to superenhancers active in hematopoietic progenitors, or focal amplifications that generate a superenhancer from a noncoding element distal to BCL11B. Chromatin conformation analyses demonstrated long-range interactions of rearranged enhancers with the expressed BCL11B allele and association of BCL11B with activated hematopoietic progenitor cell cis-regulatory elements, suggesting BCL11B is aberrantly co-opted into a gene regulatory network that drives transformation by maintaining a progenitor state. These data support a role for ectopic BCL11B expression in primitive hematopoietic cells mediated by enhancer hijacking as an oncogenic driver of human lineage-ambiguous leukemia. Significance: Lineage-ambiguous leukemias pose significant diagnostic and therapeutic challenges due to a poorly understood molecular and cellular basis. We identify oncogenic deregulation of BCL11B driven by diverse structural alterations, including de novo superenhancer generation, as the driving feature of a subset of lineage-ambiguous leukemias that transcend current diagnostic boundaries. This article is highlighted in the In This Issue feature, p. 2659

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-21-0145

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 180

Metadata

Authors
Montefiori, L. E., Bendig, S., Gu, Z., Chen, X., Pölönen, P., Ma, X., Murison, A., Zeng, A., Garcia-Prat, L., Dickerson, K., Iacobucci, I., Abdelhamed, S., Hiltenbrand, R., Mead, P. E., Mehr, C. M., Xu, B., Cheng, Z., Chang, T.-C., Westover, T., Ma, J., Stengel, A., Kimura, S., Qu, C., Valentine, M. B., Rashkovan, M., Luger, S., Litzow, M. R., Rowe, J. M., den Boer, M. L., Wang, V., Yin, J., Kornblau, S. M., Hunger, S. P., Loh, M. L., Pui, C.-H., Yang, W., Crews, K. R., Roberts, K. G., Yang, J. J., Relling, M. V., Evans, W. E., Stock, W., Paietta, E. M., Ferrando, A. A., Zhang, J., Kern, W., Haferlach, T., Wu, G., Dick, J. E., Klco, J. M., Haferlach, C., & Mullighan, C. G.
Venue
Cancer Discovery
Published
2021-06-08
Volume
11
Issue
11
Pages
2846-2867
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W3170908410
Cited by
180
References
24
FWCI
15.68
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.